NHS England's medical director is alarmed by the inappropriate use of weight-loss drugs as 'a quick fix' for summer beach bodies, emphasizing the dangers of side effects.
Professor Powis highlights that weight-loss injections like Wegovy and Ozempic, containing semaglutide, should be used under medical supervision due to potential risks and complications.
The surge in interest in Wegovy for obesity treatment has led to limited supplies, while Mounjaro may soon be recommended for NHS use, indicating the growing importance of drug treatments in addressing obesity.
[
add
]
[
|
|
...
]